91 related articles for article (PubMed ID: 2884683)
1. Dopaminergic antagonists potentiate the adenohypophyseal growth reaction to oestrogen: thioridazine is less effective than perphenazine.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1987; 36(1):9-13. PubMed ID: 2884683
[TBL] [Abstract][Full Text] [Related]
2. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic modulation of the adenohypophyseal reaction to oestradiol: interaction of perphenazine with the thyroid hormones.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1980; 29(2):173-9. PubMed ID: 6446099
[TBL] [Abstract][Full Text] [Related]
4. Metoclopramide potentiates the hypophyseal reactions to oestradiol.
Schreiber V; Dusková J; Pribyl T; Svobodová V; Jahodová J
Physiol Bohemoslov; 1984; 33(5):385-9. PubMed ID: 6505072
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the effect of oestradiol on adenohypophyseal weight: ineffectiveness of nickel chloride, potentiation by cimetidine.
Schreiber V; Pribyl T; Svobodová V; Jahodová J
Physiol Bohemoslov; 1984; 33(1):11-6. PubMed ID: 6709725
[TBL] [Abstract][Full Text] [Related]
6. Modulation oestradiol effects by silver nitrate: inhibition of the adenohypophyseal reaction, block of the ceruloplasmin increase and block of hypothalamic ascorbic acid depletion.
Schreiber V; Pribyl T; Jahodová J
Endokrinologie; 1980 Oct; 76(2):129-36. PubMed ID: 7449747
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic control of adenohypophyseal growth.
Schreiber V
Vopr Biokhim Mozga; 1978; 13():221-7. PubMed ID: 756643
[TBL] [Abstract][Full Text] [Related]
9. Partial inhibition of oestrogen-induced adenohypophyseal growth by silver nitrate.
Pribyl T; Jahodová J; Schreiber V
Horm Res; 1980; 12(5):296-303. PubMed ID: 7399401
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
[TBL] [Abstract][Full Text] [Related]
11. Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and the adenohypophysis to oestradiol: inhibition by L-thyroxine.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1980; 29(1):11-20. PubMed ID: 6444734
[TBL] [Abstract][Full Text] [Related]
12. The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1978; 27(4):301-7. PubMed ID: 151286
[TBL] [Abstract][Full Text] [Related]
13. Effect of interaction of oestrogen, testosterone and thyroid hormones on the serum ceruloplasmin level in rats.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; (2):129-37. PubMed ID: 140385
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar inhibition in prolactin cells after combined thyroid hormone plus lisuride treatment in estrogenized rats.
Dusková J; Schreiber V
Endocrinol Exp; 1989 Sep; 23(3):185-94. PubMed ID: 2572415
[TBL] [Abstract][Full Text] [Related]
15. [Reactions in the rat hypophysis induced by estrogens--changes after administration of thioridazine and perphenazine].
Dusková J; Schreiber V; Jahodová J
Cesk Patol; 1987 Mar; 23(1):55-9. PubMed ID: 3581240
[No Abstract] [Full Text] [Related]
16. Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone.
Lassen JB
Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):418-29. PubMed ID: 576565
[TBL] [Abstract][Full Text] [Related]
17. Antioestrogenic action of the aldosterone antagonist canrenoate K in the rat (adenohypophysis, ceruloplasmin).
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; 26(5):385-95. PubMed ID: 144921
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1978; 27(4):308-12. PubMed ID: 151287
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic control of adenohypophysial weight and serum ceruloplasmin level in rats.
Schreiber V; Pribyl T
Neuroendocrinology; 1976; 21(1):58-67. PubMed ID: 1004686
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between the weight of adenohypophysis, thyroxine-binding adenohypophyseal proteins in vitro and level of ceruloplasmin in the rat serum: effect of hormones and of various neurotrophic drugs].
Schreiber V
Cesk Fysiol; 1976; 25(1):31-4. PubMed ID: 815007
[No Abstract] [Full Text] [Related]
[Next] [New Search]